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Abstract
Nuclear factor of activated T cells (NFAT) is a family of transcription factors composed of five proteins. Among them, NFAT1
is a predominant NFAT protein in CD4
+ T cells. NFAT1 positively regulates transcription of a large number of inducible
cytokine genes including IL-2, IL-4, IL-5 and other cytokines. However, disruption of NFAT1 results in an unexpected increase
of IL-4. In this study, we have investigated the role of NFAT1 in regulation of IL-4 gene expression in T helper 2 cells (Th2)
from an epigenetic viewpoint. NFAT1 deficient Th2 cells showed a sustained IL-4 expression while wild type (WT) cells
reduced its expression. We tested whether epigenetic maintenance and changes in the chromatin architecture of IL-4
promoter locus play a role in differential IL-4 transcription between in WT and NFAT1 deficient Th2 cells. Compared with WT,
NFAT1 deficient CD4
+ Th2 cells exhibited enhanced chromatin accessibility with permissive histone modification and DNA
demethylation in the IL-4 promoter region. Transcription factors bound to IL-4 promoter region in the absence of NFAT1
were identified by Micro-LC/LC-MS/MS analysis. Among the candidates, preferential recruitment of JUNB to the IL-4
promoter was confirmed by chromatin immunoprecipitation analysis. Overexpression of JUNB together with SATB1
synergistically upregulated IL-4 promoter activity, while knockdown JUNB significantly reduced IL-4 expression. Our results
suggest that the prolonged IL-4 expression in NFAT1 deficient Th2 cells is mediated by preferential binding of JUNB/SATB1
to the IL-4 promoter with permissive chromatin architecture.
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Introduction
T cell receptor (TCR) signaling drives T lymphocyte gene
expression and activation of nuclear factor of activated T cells
(NFAT) [1]. NFAT proteins regulate transcription of a large
number of inducible genes in immune system including diverse
cytokines, costimulatory factors and their receptors [1,2]. NFATs
are rapidly activated by calcineurin phosphatase after TCR
engagement, and return back to inactive phosphorylated states by
several kinases within a short period of time [3,4,5,6]. The
dephosphorylation and phosphorylation of NFAT regulates its
functional activity by affecting its subcellular localization, duration
of nuclear residence, interacting partners, DNA binding activity
and its transcriptional activity [4]. The NFAT family of
transcription factors is composed of five proteins. Among them,
NFAT1 is a predominant NFAT protein in T cells and accounts
for 90% of total NFAT DNA binding activity in wild type T cells
[7]. NFATs mainly work as transcriptional activators during the
immediate early time and determine the subsequent gene
expression program. NFAT1 positively regulates transcription of
a large number of inducible cytokine genes including IL-2, IL-4,
IL-5 and other cytokines as well [1]. However, disruption of
NFAT1 results in an unexpected increase of IL-4 upon stimulation
[8]. Mice lacking NFAT1 show a modest splenomegaly,
hyperproliferation of T and B cells and dysregulated production
of IL-4 [8,9,10,11,12,13]. Furthermore, in the absence of NFAT1
and NFAT4, naı ¨ve CD4
+ T cells intrinsically differentiate into the
T helper type 2 (Th2) cell direction, even in the absence of
endogenous IL-4, and are hyperresponsive to TCR-mediated
activation [14]. Although some phenotypes of NFAT1/4-deficient
mice are due to defect in lymphocyte apoptosis [15], the cause of
the various abnormalities still remains unknown.
Optimal gene expression requires recruitment of specific
transcription factors to the regulatory regions (enhancers and
promoters) of their target gene loci with permissive chromatin
structure. Changes in the remodeling of chromatin structure are
accompanied by epigenetic modifications such as changes in post-
translational modification of specific histone residues and DNA
methylation statues of CpG island. Epigenetic modifications affect
gene transcription by altering the accessibility of distinct DNA
regions to transcription factors and other DNA binding molecules
[16,17,18]. Among histone modifications, acetyl histone H3 lysine
9/14 (AcH3K9/14) and dimethyl histone H3 lysine 4 (H3K4me2)
are associated with actively transcribed genes required for T cell
function and development, whereas trimethyl histone H3 lysine 27
(H3K27me3) is associated with silent genes [19]. In addition,
methylated CpG inhibits the access of transcriptional machinery
and decreases transcriptional activity [20,21,22]. Several groups
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s have observed that epigenetic regulation is crucial for controlling
IL-4 gene expression [23,24,25,26,27].
Special AT-rich sequence-binding protein-1 (SATB1) is a global
chromatin organizer and transcription factor. It plays a key role in
forming a transcriptionally poised chromatin [28,29] to induce
gene expression in response to physiological stimuli [30]. SATB1
also organizes the IL-4 locus into distinct chromatin loops by
tethering matrix associated regions (MARs) to the nuclear matrix
at fixed distances. Upon Th2 cell activation, SATB1 is also
required for the expression of IL-4, IL-5, and IL-13 through
formation of transcriptionally active chromatin structure [29].
In this study, we have investigated the underlying mechanism of
IL-4 gene expression in the absence of the key transcription factor
NFAT1 in Th2 cells. We and others have found that Th2 cells
lacking NFAT1 still express high levels of IL-4. Prolonged
expression of IL-4 was observed in NFAT1 deficient Th2 cells
upon TCR engagement at late time points compared with wild
type Th2 cells. We tested the possibility that NFAT1 deficiency
may bring a change in the chromatin architecture in the IL-4
promoter and recruitment of other transcription factors may
replace the transactivity of NFAT1 to mediate prolonged IL-4
expression. Here we show that the sustained IL-4 expression is
mediated by a permissive chromatin change and by the
recruitment of JUNB/SATB1/coactivator complex upon TCR
stimulation in NFAT1-deficient Th2 cells.
Results
IL-4 expression is sustained in NFAT1 deficient Th2 cells
compared with WT
NFAT1 positively regulates IL-4 gene transcription in CD4
+ T
cells. However, disruption of NFAT1 results in an unexpected
prolonged increase of IL-4 upon stimulation. Anti-CD3 (a-CD3)
stimulation significantly increased IL-4 transcripts in NFAT1
deficient CD4
+ T cells than in WT mice [8,14]. To elucidate the
underlying mechanism of IL-4 expression in the absence of
NFAT1, Th2 cells differentiated from wild type (WT) or lacking
NFAT1 (NFAT1 KO) mice were stimulated with anti-CD3 for the
indicated time periods and the IL-4 at mRNA and protein levels
were determined by quantitative real-time PCR and ELISA,
respectively. In line with previously published data [8], NFAT1
deficient Th2 cells maintained much higher levels of IL-4
expression than WT cells till later time points (Fig. 1). The IL-4
mRNA level showed a peak expression at 3 h after stimulation in
WT cells followed by a rapid decline. Since NFAT1 is rapidly
activated through dephosphorylation within 1 h and then returned
to the phosphorylated inactive form (Fig. S1A), IL-4 gene
transcription at the early time (,1 h) might be mainly mediated
by NFAT1 activation. In NFAT1 deficient T cells, however, the
IL-4 mRNA levels were progressively increased until 6 h and were
then maintained at much higher level compared with WT (Fig. 1).
Enhanced IL-4 protein level was also observed in Th2 cells lacking
NFAT1 compared with WT Th2 cells analyzed by ELISA (Fig.
S1B).
The IL-4 promoter of NFAT1 deficient Th2 cells has more
permissive chromatin structure
IL-4 expression is mainly mediated by the NFAT1 at
immediately early time points (Fig. 1A). However, underlying
mechanism for higher IL-4 expression in NFAT1 deficient CD4
+
T cells is still unknown. To test the role of epigenetic change in
these states, we compared chromatin accessibility to micrococcal
nuclease (MNase) at the IL-4 promoter between WT and NFAT1
deficient Th2 cells. Nuclei isolated from Th2 cells of WT and
NFAT1 KO mice were stimulated for 6 h with anti-CD3 and
were incubated with MNase for 5 min at room temperature. The
amount of amplified genomic DNA from each treatment was
quantitatively measured by real-time PCR with primer sets
specific for IL-4 promoter (Table 1). IL-4 promoter was more
accessible in NFAT1 deficient Th2 cells than in WT (Fig. 2A). To
address transcriptional activity as a marker for active chromatin,
the amount of recruited RNA polymerase II (Pol II) to the IL-4
promoter and within the body of the IL-4 gene (Exon1) was
assessed by ChIP assay using phospho-Pol II antibody. The
enrichment of the phospo-Pol II molecule was observed at
promoter (Fig. 2B) and within the body of the IL-4 gene (data not
shown) in the NFAT1 deficient Th2 cells compared with the WT
cells. To further confirm whether the differential chromatin
accessibility at the IL-4 promoter between WT and NFAT1 KO
Th2 cells is accompanied by epigenetic modification, we
performed ChIP analysis with specific antibodies for modified
histone molecules by quantitative real-time PCR analysis. In
general, modification of acetylated H3 at lysine residue 9 and 14
(AcH3K9/14) and trimethylated H3 at lysine 27 (H3K27me3)
are well correlated with actively transcribed or silenced region,
respectively. In both WT and NFAT1 deficient Th2 cells,
amounts of AcH4K9/14 were significantly increased upon
stimulation, whereas H3K27me3 levels were decreased at the
IL-4 promoter (Fig. 2C). However, NFAT1 deficient Th2 cells
showed significantly elevated AcH3K9/14 binding levels com-
pared with WT cells at the IL-4 promoter (Fig. 2C). As a control
Figure 1. Sustained IL-4 expression in NFAT1 deficient Th2
cells. Th2 cells differentiated in vitro from WT or NFAT1 KO mice were
stimulated with anti-CD3 (a-CD3) for indicated time periods and IL-4
mRNA levels were measured by quantitative RT-PCR by normalizing
with b-actin levels (A). PCR products were visualized on ethidium
bromide-stained agarose gels (B). Data shown are the mean 6 SEM
from four separate experiments and * P,0.05, ** P,0.01.
doi:10.1371/journal.pone.0022042.g001
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stimulation, the amount of recruited levels of AcH4K9/14 or
H3K27me3 at the action promoter was similar between WT and
NFAT1 deficient Th2 cells (Fig. 2C). These results suggest that
more permissive chromatin structure in NFAT1 deficient CD4
+
Th2 cells compared with WT cells at the IL-4 promoter is related
with sustained higher IL-4 expression.
CpG sites at the IL-4 promoter of NFAT1 deficient Th2
cells are preferentially demethylated
Generally hypermethylation of DNA at the gene promoters or
CpG island is associated with transcriptional repression while
hypomethylation is associated with actively transcribed genomic
locus. To test whether the differential methylation statute of IL-4
promoter between WT and NFAT1 deficient Th2 cells is involved
in differential IL-4 expression between them, we analyzed the
DNA methylation status at the IL-4 promoter by pyrosequencing.
Under unstimulated condition, little difference in the methylation
status was observed between NFAT1 deficient (68%) and WT
(74%) Th2 cells. Six hours after stimulation, however, the level of
methylated DNA in the IL-4 promoter of NFAT1 deficient Th2
cells was significantly decreased (55%) than that of WT (74%) Th2
cells (Fig. 3A and Fig. S2). To confirm this observation, we next
assessed the levels of enriched methylated DNA at the IL-4 locus
by methylated DNA immunoprecipitation assay. In line with the
pyrosequencing data, a significant decrease of demethylated DNA
at the IL-4 promoter was observed in NFAT1 deficient cells
compared with WT Th2 cells (Fig. 3B). As a control, methylated
DNA levels were also measured at the FoxP3 and beta-actin gene
locus as controls for repressed or active gene, respectively. These
results suggest that DNA hypomethylation at the IL-4 promoter of
NFAT1 deficient Th2 cells is related with sustained higher IL-4
expression.
Preferential recruitment of JUNB to the IL-4 promoter in
NFAT1 deficient Th2 cells
The higher expression level of IL-4 in NFAT1 deficient Th2
cells than WT cells suggests that transcription factors other than
NFAT1 may bind to the accessible IL-4 promoter to transactivate
IL-4 expression. To identify the transcription factors bound at IL-
4 promoter we performed EMSA and Micro-LC/LC-MS/MS
analysis. IL-4 promoter contains binding sites for important
transcription factors [31,32,33] (Fig. 4B). Jurkat T cells (human T
cell lymphoma cell line) or Th2 cells from WT or NFAT1 deficient
cells were stimulated by PMA/ionomycin or anti-CD3 for 6 h,
respectively and then nuclear extracts were prepared. Oligomers
corresponding to P2 (-196 to -163) locus of IL-4 promoter were
incubated with the isolated nuclear proteins and then EMSA
analysis was performed. IkB probe was used as a positive control
for the binding of the NF-kB complex and EF-1 probe was used as
a loading control. The regulatory element P2 was shown to
interact with nuclear proteins of Th2 cells (Fig. 4A). Bands
Table 1. List of oligonucleotide primer sequence (59 to 39).
Sense Antisense Product size (bp)
CHART (Chromatin accessibility real time PCR)
-393 TCAAGGCAGACTTTCTTGATATTACTCTGT AATCAGCACCTCTCTTCCAGGAGAA 279
-195 GTGTTTCATTTTCCAATTGGTCT AATCAGCACCTCTCTTCCAGGAGAA 81
actin AGCACAGCTTCTTTGCAGCTCCTT AGGACCCTGCAGTGAGGTACTA 117
ChIP (Chromatin immunoprecipitation)
-278 GATAAGATTAGTCTGAAAGGCCGATTATG AATCAGCACCTCTCTTCCAGGAGAA 164
-195 GTGTTTCATTTTCCAATTGGTCT AATCAGCACCTCTCTTCCAGGAGAA 81
actin AGCACAGCTTCTTTGCAGCTCCTT AGGACCCTGCAGTGAGGTACTA 117
EMSA
ikB AGCTTCAGAGGGGACTTTCCGAGAGG CCTCTCGGAAAGTCCCCTCTGAAGCT
P1 GGAGGGGTGTTTCATTTTCCAATTGGTCTGATTTC GAAATCAGACCAATTGGAAAATGAAACACCCCTCC
P2 CTGGTGTAATAAAATTTTCCAATGTAAACTCATTT AAATGAGTTTACATTGGAAAATTTTATTACACCAG
RT-PCR
IL-4 CAACGAAGAACACCACAGAG GGACTTGGACTCATTCATGG 192
IL-2 ACCTCTGCGGCATGTTCTGGATTTGACTC CCTCAGAAAGTCCACCACAGTTGCT 169
JunB AGGTGAAGACACTCAAGGCTGAGAA TGACATGGGTCATGACCTTCTGCTT 102
Actin CTGTGGCATCCATGAAACTACATTCAAT AGGAGGAGCAATGATCTTGATCTTCA 145
aLuc constructs
GAAGATCTAAATCTTCAACCTAGCCCAG GGGAAGCTTTTGAGCTTTGTCCCTAGTCC 977
Pyrosequencing analysis
GATATCAGAGTTTCCAAG AGAGAAGGAAGAGGTCACAGGT 140
MeDIP
IL-4 ACAAACTTGTAAGATCAGCTGGTCT ATCTACAAAGTTTCAGCATAGGAAATTA 322
FoxP3 TGCAAAGACCCTAGCTTTACACTTCAGT ACCAAACCATGGACCCTGAGAAAAT 204
actin GGCCAGCGTTTGCCTTTTATGGTAATAAT TATAGCCTTCTTTTGTGTCTTGATAGTTCG 181
aLuc, luciferase.
doi:10.1371/journal.pone.0022042.t001
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deficient cells were cut and then the identity of binding proteins
were analyzed by Micro-LC/LC-MS/MS analysis (Table 2).
Jurkat nuclear extract showed the NF-kB complex (lane 1) and
NFAT/AP1 complex (Lane 6) (Fig. 4A). Nuclear extracts of
NFAT1 deficient Th2 cells showed a much stronger signal of
STAT (lane 9), SATB1/JUNB (lane 9) complex incubated with P2
element than WT Th2 cells (Fig. 4A lane 12). Formation of EF-1
binding complex was same between WT and NFAT1. This result
suggests that preferential binding of JUNB/SATB1 to the P2
Figure 2. NFAT1 deficient Th2 cells have more permissive chromatin structure at the IL-4 promoter. (A) For chromatin accessibility
analysis, Th2 cells differentiated in vitro from WT or NFAT1 KO mice were stimulated with anti-CD3 for 6 h. Nuclei isolated from each group and were
incubated with or without 50 U Mnase. Fifty nanograms of genomic DNA from each treatment were subjected to real-time PCR analysis with indicated
primer sets covering IL-4 promoter. The Ct values generated were converted to DNA concentrations by using the standard curve. MNase accessibility
was expressed as a relative value of undigested genomic DNA and plotted for each primer set. Graphs depict the PCR products from digested samples
normalized to the PCR products from undigested samples and show mean 6 SEM, n=3 and ** P,0.01 for four separate experiments. To measure the
mounts of recruited Pol II and modified histone molecules at the IL-4 promoter, ChIP analysis was performed with antibodies specific for RNA Pol II (B)
and acetyl histone H3 lysine 9/14 (AcH3K9/14), trimethyl histoneH3 lysine 27 (H3K27me3) or isotype matched control IgG (C). Relative amount of
enrichedDNAbyChIP wasmeasuredbyquantitative RT-PCRusingtheprimers spanningtheindicatedIL-4 promoterregionor b-actin region. Thegraph
represents mean 6 SEM, from four separate experiments and * P,0.05, ** P,0.01.
doi:10.1371/journal.pone.0022042.g002
Figure 3. Increased DNA demethylation status at the IL-4 promoter of NFAT1 deficient Th2 cells. Th2 cells from WT or NFAT1 KO mice
were stimulated with anti-CD3 for 6 h or left without stimulation. DNA methylation state at the IL-4 promoter was analyzed by pyrosequencing (Fig.
S2) and ChIP analysis using anti-5mC antibodies specific for methylated DNA at IL-4 promoter (B). FoxP3 and b-actin locus were tested as positive or
negative control, respectively for methylated DNA experiment, (C). The relative amount of enriched methylated DNA was assessed by real-time PCR
analysis. 10% of the input sample was used for PCR amplification and normalized to the input samples from three independent experiments and
*P ,0.05, ** P,0.01.
doi:10.1371/journal.pone.0022042.g003
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sustained IL-4 expression.
To further test whether the identified proteins by Micro-LC/
LC-MS/MS analysis are also recruited to the IL-4 promoter (P2
region) in vivo, ChIP assay was performed. WT and NFAT1
deficient Th2 cells were stimulated with anti-CD3 for 6 h and
DNA-protein complex were enriched by use of specific antibodies
for SATB1, JUNB, and other cofactors such as P300, PCAF, and
HDAC1. The relative amounts of enriched P2 region from each
ChIP experiment were measured by quantitative RT-PCR.
Indeed, in vivo binding of JUNB, P300, and PCAF to the P2
region of IL-4 promoter were enriched in a stimulation-
dependent manner (Fig. 5). Compared with WT cells, significant
increase of JUNB (Fig. 5A) and PCAF (Fig. 5D) binding in
NFAT1 deficient cells was observed while the level of SATB1
binding (Fig. 5B) was similar between WT and NFAT1 deficient
cells regardless of stimulation. We also analyzed the relative levels
of recruited HDAC1 as a SATB1-interacting partner of repressor
complex. Interestingly, a significant decrease of HDAC1 binding
to the P2 region of IL-4 promoter was observed in NFAT1
deficient cells compared with WT cells in a stimulation-
dependent manner (Fig. 5E). As a negative control for ChIP
experiments, isotype matched normal IgG data was included
(Fig. 5F). This result suggests that in vivo binding of JUNB/
SATB1 together with transcriptional coactivators (P300 and
PCAF) complex to the IL-4 promoter mediates IL-4 expression in
NFAT1 deficient Th2 cells.
SATB1 and JUNB synergistically transactivate the IL-4
promoter
To test the functional role of SATB1 and JUNB recruitment in
vivo to the IL-4 promoter, we performed IL-4 reporter analysis by
measuring luciferase activity driven by IL-4 promoter. IL-4
reporter construct was transfected into HEK cells in the presence
of SATB1 or JunB expression plasmids alone or together, and then
luciferase activity was measured. SATB1 alone failed to activate
IL-4 promoter activity while JunB alone significantly activated it
(Fig. 6A). However, co-transfection of SATB1 with JunB
Figure 4. Identification and analysis of IL-4 promoter-binding transcription factors. EMSA assay was carried out with nuclear extracts
prepared from Th2 cells of WT and NFAT1 KO or from Jurkat cells that were stimulated with anti-CD3 for 6 h or PMA/I for 2 h, respectively (A).
32P-labelled P2 probes were incubated with indicated nuclear extracts. IkB probe containing kB element was used as a positive control and 100 pmol
unlabeled ikB probe was used as a competitor to interfere the complex formation. (2)o r( +) indicates in the absence or presence competitor,
respectively. The DNA binding complexes that appeared or were enhanced after stimulation are indicated. Arrows indicate the identified proteins
that bound to the corresponding gel band. Equal loading of nuclear extracts was controlled by using the binding site for the constitutive factor EF-1
as a probe. Identification of DNA-binding transcription factors was carried out by micro-LC/LC-MS/MS analysis as described in Material and Methods.
(B) Predicted DNA binding elements for the P2 region of IL-4 promoter.
doi:10.1371/journal.pone.0022042.g004
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dependent manner (Fig. 6A). Since transcription coactivators such
as P300 and PCAF also bind to the IL-4 promoter in vivo (Fig. 5),
we tested whether expression of transcription coactivators (P300
and PCAF) together SATB1/JunB could further enhance the IL-4
promoter activity. Indeed, overexpression of the PCAF and/or
p300 cofactors significantly enhanced transactivation activity
(Fig. 6B). In the formation of transcriptional activation complex,
JUNB may play a pivotal role through interaction with SATB1
and coactivators since SATB1 alone failed to activate IL-4
promoter activity while overexpression of JunB enhanced it in a
dose-dependent manner (Fig. 6A). To further validate the JUNB-
dependent IL-4 gene activation we tested the knockdown effect of
JUNB by using JunB siRNA (si-JunB) in WT and NFAT1 deficient
Th2 cells. We first confirmed that stimulation of Th2 cells with
anti-CD3 significantly upregulated IL-4 expression (Fig. 6C and
Fig. S4A). Then cells were transfected with scrambled or si-JunB.
Overexpression of si-JunB successfully reduced JunB levels (Fig. 6D
and Fig. S4B), which significantly reduced IL-4 transcript levels
compared with mock siRNA treatment (Fig. 6D). These results
suggest that JUNB plays pivotal role to induce IL-4 expression
through coordinated interaction with other coactivators in Th2
cells.
Discussion
NFAT1 is a crucial transcription transcriptional activator and
regulates expression of cytokines and other inducible genes in
immune cells. However, NFAT1 deficiency results in hyperre-
sponsiveness and sustained expression of IL-4 in CD4
+ Th2 cells
upon TCR stimulation. In this study, we have investigated the
molecular mechanism of sustained IL-4 gene expression in NFAT1
deficient T helper 2 cells. Our results showed that sustained IL-4
expression in NFAT1 deficient Th2 cells is mediated by enhanced
Table 2. Proteins of interest and their peptide sequences detected by micro LC/LC-MS/MS analysis.
Protein Peptide sequence
Special AT-rich sequence-binding protein-1 (SATB1) R.LLAQQSLNQQYLNHPPPVSR.S R.AGISQAVFAR.V R.TQGLLSEILR.K
Nuclear factor kappa-B (NF-kB) R.YVCEGPSHGGLPGASSEK R.RLEPVVSDAIYDSK.A K.VIVQLVTNGK.N
Jun-B oncogene (JUNB) R.GPGPEGSGAGSYFSGQGSDTGASLK.L R.GASAFKEEPQTVPEAR.S K.AENAGLSSAAGLLR.E
Nuclear factor of activated T-cells (NFAT1) R.IEVQPKPHHR.A
Jun oncogene (c-Jun) R.ELTDTLQAETDQLEDEKSALQTEIANLLK.E
Signal-transducer and activator of transcription protein (STATs) R.GQATQLLEGLVQELQK.K R.LITQDTENELKK.L R.EAQTLQQYR.V K.FLEQVHQLYDDSFPMEIR.Q
R.FHDLLSQLDDQYSR.F R.FHDLLSQLDDQYSR.F R.FSLENNFLLQHNIR.K
R.FNQAQEGNIQNTVMLDK.Q R.ELLNSIELTQNTLINDELVEWK.R K.FTYEPDPITK.N
R.TFLLFQQLIQSSFVVER.Q K.LLGPNAGPDGLIPWTR.F R.EGAITFTWVER.S K.TELISVSEVHPSR.L
- Number indicates the frequency of unique peptide of the detected protein.
doi:10.1371/journal.pone.0022042.t002
Figure 5. In vivo binding of JUNB, SATB1 and cofactors to the IL-4 promoter. Th2 cells from WT or NFAT1 KO mice were stimulated with
anti-CD3 for 6 h or left without stimulation. The relative amount of DNA-protein complex enriched at the P2 locus of IL-4 promoter was analyzed by
ChIP using control normal IgG (F) or specific antibodies for JUNB (A), SATB1 (B), and other cofactors such as P300 (C), PCAF (D) and HDAC1 (E). Relative
enrichment at the P2 locus of IL-4 promoter in the precipitated samples compared to total chromatin (input) is shown. Data are representative of
three independent experiments and * P,0.05, ** P,0.01.
doi:10.1371/journal.pone.0022042.g005
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DNA demethylation in the IL-4 promoter. Furthermore, prefer-
ential recruitment of JUNB/SATB1 with transcriptional coacti-
vators (PACF and P300) to the IL-4 promoter mediates continual
IL-4 expression in the absence of NFAT1.
NFAT is a family of transcription factors composed of five
proteins. These include NFAT1 (NFATp, NFATc2), NFAT2
(NFATc, NFATc1), NFAT3 (NFATc4), NFAT4 (NFATx,
NFATc3), and NFAT5 (TonEBP: tonicity element binding protein
or OREBP: osmotic response element binding protein). The role
of NFAT1 as a transcriptional activator has been well documented
in regulation of diverse target genes including cytokines and
costimulatory factors [1]. Depending on their binding partners,
however, the transcriptional activity of NFATs can be varied as an
activator or inhibitor. For example, coupling with AP-1 (composed
of Fos and Jun proteins) or MEF2 activates gene expression while
in the absence of cooperative binding with AP-1 in the nucleus or
alternative binding with histone deacetylases (HDACs) turns on a
negative regulatory gene program [34,35]. Specific role of NFAT
proteins were investigated by knockout mice models [36]. NFAT1
is a predominant NFAT protein in T cells [7] and mainly
enhances cytokine expression including IL-4 by lowering the
threshold for TCR-mediated activation [14]. Interestingly,
however, disruption of NFAT1 enhanced IL-4 expression
especially at the later stage of stimulation. What is the underlying
mechanism of IL-4 gene regulation in the absence of NFAT1? In
addition, how come IL-4 gene expression is more sustained in
NFAT1 deficient Th2 cells than WT? Since NFAT1 also works as
Figure 6. SATB1 and JUNB synergistically transactivate IL-4 promoter with other cofactors. (A) IL-4 reporter construct was transfected
into HEK cells in the presence of different amount (0, 0.2 mg( +) or 0.4 (++) mg) of SATB1 or JunB expression plasmid alone or both of them, and then
luciferase activity was measured. In each transfection, 0.1mg of TK-luciferase plasmid was added as an internal control for normalization of
transfection efficiency. Transfected cells were harvested after 24 h in reporter lysis buffer, and analyzed for luciferase activity. (B) IL-4 reporter
construct was transfected into HEK cells, in duplicate, with 0.2 mg of STATB1/JunB expression plasmids, in the absence or presence of 0.2 mg of p300
or/and PCAF expression plasmids. In each transfection, 0.1 mg of TK-luciferase plasmid was added and total DNA was maintained at 0.8 mgb y
addition of the appropriate amounts of pcDNA3 control plasmid. After 24 h, cells were harvested and analyzed for firefly and Renilla luciferase
activities. Values were normalized to Renilla activities. The graphs in A-B represents mean 6 SEM, n=3 and * P,0.05, ** P,0.01. Data are
representative of three independent experiments. (C) Th2 cells from WT or NFAT1 deficient were left without stimulation or stimulated for 6 h. The
expression levels of JunB and IL-4 were measured by RT-PCR. (D) Th2 cells from WT and NFAT1 deficient mice were transfected with scrambled mock
siRNA (Mock) or JunB specific siRNA (si-JunB) and then specific knockdown efficiency of JunB and its effect on IL-4 expression level was measured by
RT-PCR. Data are representative of three independent experiments and * P,0.05, ** P,0.01.
doi:10.1371/journal.pone.0022042.g006
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hypothesized that in the absence of NFAT1, changes in the
chromatin structure at the IL-4 promoter might be different
between WT and NFAT1 deficient Th2 cells. Indeed, chromatin
accessibility at the IL-4 promoter was significantly increased in
NFAT1 deficient cells compared with WT cells (Fig. 2A), which is
further confirmed by the enhanced recruitment of phospho-Pol II
in NFAT1 deficient Th2 cells (Fig. 2B). In addition, permissive
chromatin architecture related with epigenetic modification
showed a close correlation. Compared with WT cells, there was
enhanced modification of active chromatin marker histones
(AcH3K4Me2, AcH3K9/14). In addition, reduction of methylat-
ed DNA and H3K27me3 was observed in NFAT1 deficient Th2
cells compared with WT (Fig. 2C). Interestingly, significant
reduction of HDAC1 recruitment was observed in NFAT1
deficient cells than WT upon stimulation (Fig. 5E). It seems that
NFAT1 may act not only as an activator during the immediate
early time (,1 h) after stimulation in WT cells, but also as an
inhibitory molecule at later time points (.1 h) in Th2 cells (Fig.1),
possibly through interaction of HDAC1. Few studies suggest the
potential role of NFAT as a transcription repressor through
interaction of HDAC molecules. A reduction in acetylation of
histone H3 within the CDK4 promoter and direct association of
NFAT1 with HDAC1 suppressed cyclin-dependent kinase 4 (cdk4)
gene expression [37]. NFAT1 deficient mice showed increased
expression of type II and type X collagen [38]. In addition, in our
own studies on the transcription regulation of IL-10 gene in T
cells, we found that HDAC1 is constitutively associated with intron
4 [39] and promoter (Lee et al, unpublished) of the IL-10 gene in
Th1 cells, which may contribute to Th1-specific silencing of IL-10
expression in CD4
+ T cells.
In the absence of NAFT1 which transcription factors mediate
IL-4 expression by binding to the IL-4 promoter? To answer this
question we performed EMSA-based Micro-LC/LC-MS/MS
analysis and following proteins were identified such as special
AT-rich sequence-binding protein-1 (SATB1), nuclear factor
kappa-B (NF-kB), Jun-B oncogene (JUNB), NFAT, Jun oncogene
(c-Jun), signal-transducer and activator of transcription protein
(STAT) (Table 2). Interestingly, the list of identified proteins were
matched well with the predicted data by bioinformatic analysis
[40] (Fig. 4B). Among the identified proteins, JUNB, SATB1 and
STAT were specifically enriched in NFAT1 deficient nuclear
extract compared with WT Th2 cells (Fig. 4A). The appearance of
this complex means that the NFAT1 complex is replaced at the IL-
4 promoter by other transcriptional factor complexes after long
term (6 h) stimulation. This complex might influence the
regulation of IL-4 expression. JUNB also was identified as the
partner of SATB1. JUNB is an abundant and inducible protein
expressed in Th2 cells and has a cooperative role of SATB1 in IL-
4 expression (Fig. 6A). Indeed, ChIP analysis showed the in vivo
binding of JUNB and SATB1 at the IL-4 promoter (Fig. 5).
Interestingly, preferential binding of JUNB was observed in
NFAT1 deficient cells compared with WT Th2 cells while SATB1
binding levels were same between them (Fig. 5). In addition, no
significant difference in the nuclear levels of SATB1 was observed
between the cells (Fig. S3A). Among the JUNB and SATB1
proteins, JUNB may play a pivotal role in transactivation of the IL-
4 gene expression. Overexpression of JUNB significantly activated
IL-4 promoter activity while knockdown of JUNB reduced IL-4
expression. In JUNB-mediated IL-4 promoter activation, SATB1
may play a synergistic role to activate JUNB function rather than
transactivate IL-4 promoter activity by itself since overexpression
of SATB1 alone failed to enhance IL-4 promoter activity (Fig. 6A).
SATB1 organizes cell type specific nuclear architecture by
anchoring specialized DNA sequences and recruiting chromatin
remodeling factors to regulate gene transcription [41]. It is also
required for expression of IL-4, IL-5, and IL-13 in a Th2 type
specific manner by rapidly inducing a transcriptionally active
chromatin structure at the cytokine locus [28,29]. Therefore,
recruitment of JUNB together with SATB1 may help to form an
active chromatin complex at the IL-4 promoter. Indeed, enriched
P300 and PCAF were observed at the IL-4 promoter in a
stimulation dependent manner (Fig. 5). SATB1 interacts with both
P300 and P300/CBP-associated factor (PCAF), a transcriptional
coactivator with intrinsic histone acetylase activity [28]. Indeed,
overexpression of transcription coactivators (P300 and PCAF)
together with SATB1/JUNB further enhanced the IL-4 promoter
activity (Fig. 6B). In addition, sustained IL-4 expression levels in
NFAT1 deficient cells was well correlated with enhanced in vivo
binding of PCAF, P300 and JUNB (Fig. 5) and acetylated histones
(AcH3K9/14) (Fig. 2C) levels.
We also tested a possibility that in the absence of NFAT1, other
NFAT members expressed in CD4 T cells could have compen-
satory function to mediate sustained IL-4 expression in NFAT1
deficient Th2 cells. However no significant increase of NFAT2 or
NFAT4 was observed in NFAT1 deficient Th2 cells compared
with WT (Fig. S5A). In line with the previously published data,
NFAT1 deficiency did not alter the nuclear levels of JUNB and
IRF4, the NF-kB family (p65 and p50) and Pol II (Fig. S5A). We
also confirmed a similar nuclear JUNB level between WT and
NFAT1 deficient Th2 cells by confocal microscopy analysis (Fig.
S5B).
In conclusion, we have shown here that the sustained IL-4
expression in NFAT1 deficient Th2 cells is the result of permissive
chromatin changes through hyperacetylation of histones and
enhanced DNA demethylation in the IL-4 promoter. In addition,
preferential binding of JUNB with transcriptional coactivators to
the IL-4 promoter mediated sustained IL-4 expression in NFAT1
deficient Th2 cells.
Materials and Methods
Animals
C57BL/6 mice were purchased from SLC (Hamamatsu, Japan)
and NFAT1
-/- mice were kindly provided by Dr. Anjana Rao
(Boston, Harvard Medical School). Mice were housed in specific
pathogen-free barrier facilities. All animal procedures were
performed with the approval of Animal Care and Ethics
Committees of the Gwangju Institute of Science and Technology
(permit number: GIST-2008-12).
Cell lines and primary T cells
Jurkat T cells E6.1 were purchased from American Type
Culture Collection (ATCC, MA, USA) (Cat. Number; TIB-152).
CD4
+ T cells were purified from the spleen of 8-10-week-old
female mice with the use of magnetic beads (L3T4 MicroBeads;
Miltenyi Biotec, (Auburn, CA, USA)). For Th2 differentiation,
naı ¨ve CD4
+ cells (1610
6/ml) were stimulated with 1 mg/ml plate-
bound anti-CD3e under Th2-skewing (10 ng/ml IL-4, 10 mg/ml
anti-IFN-c plus 10 mg/ml anti-IL-12) conditions in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum, L-glutamine, penicillin-streptomycin, nonessential
amino acids, sodium pyruvate, vitamins, HEPES, and 2-
mercaptoethanol. At 24 h after stimulation, 10 U/ml recombinant
human IL-2 (rhIL-2) was added, and the cells were expanded in
complete medium containing IL-2 for 4 days. On day 6 after
resting for 2 days, the cells were re-stimulated with plate-bound
1 mg/ml anti-CD3. Recombinant human IL-2 and IL-4 (11B11)
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Repository. Anti-IFN-c (XMG1.2) and anti-IL-12 (C17.8) were
obtained from BD Biosciences (San Jose, CA) and anti-CD3
(145.2C11) and anti-CD28 (37.51) were from Pharmingen (San
Diego, CA, USA).
RNA isolation and quantitative real-time PCR
Total RNA was purified by using TRI Reagent purchased from
Invitrogen. For reverse transcription, cDNA was generated by
using 1 mg of total RNA plus oligo-dT and Improm-II Reverse
Transcriptase (Promega, WI, USA) according to the manufactur-
er’s instructions in a total volume of 20 ml. The mRNA level of IL-
4 was determined by real-time PCR with SYBR green by using a
protocol provided by the manufacturer (MJ Research Chromo 4).
One microliter of cDNA was amplified by using the RT-PCR
primer sets shown in Table 1. Expression levels were normalized
to b-actin amplification levels in each sample.
Chromatin accessibility by real-time PCR (CHART-PCR)
Chromaitn accessibility assays were performed as decribed [42]
with minor modifications. Approximately 2610
6 nuclei in 100 ul
nuclear digestion buffer (10 mM Tris-HCl pH 7.4, 15 mM NaCl,
60 mM KCl, 0.15 mM spermine, 0.5 mM spermidine, 1 mM
CaCl2) plus 5 U/ml micrococcal nuclease (MNase; Roche, Basel,
Switzerland) were incubated at 25uC for 10 min. Reactions were
terminated with 20 ml stop solution (100 mM EDTA, 10 mM
EGTA pH 8.1) and 10 ml 10% (w/v) SDS. DNA was isolated
using a DNA blood genomic prep kit (Intron, Deageon, Korea)
and eluted into 100 ml TE. DNAs recovered from MNase samples
were checked for fragmentation in a 1% agarose gel. Untreated
MNase samples were used in PCR assays to measure the relative
abundance of target regions by using the primer sets shown in
Table 1. To calculate the Ct value of each primer set, a standard
curve was generated by using serial dilutions of genomic DNA.
Chromatin accessiblity values were calculated as a ratio of the
undigested sample to the digested samples, and then the data were
plotted as the ratio of acessibility observed in the unstimulated
digested DNA samples.
Chromatin immunoprecipitation assay
The chromatin immunoprecipitation (ChIP) assay was per-
formed essentially as described [39] with minor modifications.
ChIP analysis was performed against SATB1, JUNB, P300,
PCAF, and HDAC1 from Abcam (Cambridge, UK), RNA Pol II
(Millipore, Temecula, CA; 05-623) and AcH3K9/27, H3K27me3,
or rabbit IgG antibodies from Upstates (Temecula, CA, USA).
Methylated DNA immunoprecipitation was performed as previ-
ously described [32;33] using anti-5-methylcytosine (anti-5mC)
antibodies (Diagenode, Liege, Belgium). Fragmented DNA by
Bioruptor was immunoprecipated using anti-5mC purchased from
Diagenode (Liege, Belgium). Samples were used for RT-PCR
analysis. Three independent experiments were performed. As a
loading control, PCR was performed directly on input DNA
purified from chromatin before immunoprecipitation. Quantifica-
tion of IL-4 promoter fragment following ChIP was performed by
real-time quantitative PCR. For normalization, 1% of ‘input’
DNA from each sample was analyzed in parallel and the amount
of IL-4 DNA in each sample was calculated using the equation
2-
(Ct
sample
-Ct
input
)[43], where Ct is cycle threshold [43]. Real-time
PCR detection system was carried out in triplicate. Primer
sequences are shown in Table 1. ChIP assays were used to ensure
that Ct values from samples DNA with specific antibodies resulted
from specific immunoprecipitation.
Pyrosequencing analysis
The promoter region of IL-4 (2450 , 2310) was amplified
by using the forward primer and the biotinylated reverse primer
(Table 1) designed by PSQ Assay Design (Biotage AB, Uppsala,
Sweden). Genomic DNA (20 ng) was modified by sodium
bisulfite with the EZ DNA Methylation kit (ZYMO Research,
CA, USA) according to the manufacturer’s instructions. Bisulfite-
modified DNA was amplified in a 25 ml reaction with the primer
set and 5 U/reaction of Taq polymerase (Solgent Co., Daejeon,
Korea). Samples were heated to 95uC for 10 min and were then
amplified for 40 cycles consisting of 95uC for 45 s, 55uC for 35 s,
and 72uC for 60 s. All reactions were then incubated at 72uCf o r
10 min and cooled to 4uC. The PCR products were visualized
on a 1.5% agarose gel by ethidium bromide staining for veri-
fication. Pyrosequencing reactions were done with sequencing
primers on the PSQ HS 96A System (Biotage AB, Anaheim, CA)
according to the manufacturer’s specifications. The methylation
index of each gene promoter and of each sample was calculated
as the average value of
mC ˜(
mC+C)f o ra l le x a m i n e dC p G si nt h e
target region. Statistical correlations between the methylation
index and the clinical variables recorded were made by using
SPSS version 11.
Computational analysis of the conserved nucleotide
sequence locus
Analysisof the sequencesfortranscriptionfactorbindingsiteswas
performedwiththe MatInspectorprofessional program (Genomatix
Software, Munich, Germany) [40] by using the selected matrix
library (vertebrate section) and optimized thresholds.
Nuclear extract isolation and electrophoretic mobility
shift assay
Electrophoretic mobility shift assay (EMSA) analysis was
performed by using oligonucleotides corresponding to sequences
in the NFAT/kb site in the IL-4 promoter. The oligonucleotides
shown in Table 1 and the consensus kB oligonucleotide were
purchased from Promega (Madison, WI). Complementary oligo-
nucleotide pairs were annealed in 100 mM NaCl, 10 mM Tris
pH 8.0, 0.1 mM EDTA buffer by heating to 95uC for 10 min and
cooling slowly to the annealing temperature. Double-stranded
oligonucleotides were end-labeled with [c-
32P] ATP and T4
polynucleotide kinase (Promega, Madison, WI). Labeled oligonu-
cleotides were purified by use of a microspin G-50 column
(275330, Amersham Biosciences, Uppsala, Sweden). Nuclear
extracts were prepared from Jurkat cells stimulated for 2 h with
phorbol myristate acetate (PMA)/ionomycin (P/I) and Th2 cells
stimulated with anti-CD3 for 6 h. Twenty million cells were
washed in PBS and suspended in buffer A (10 mM HEPES,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT; 500 ml) with
protease inhibitor cocktail (Roche: Mannheim,, Germany) and
5m Mb-glycerol phosphate. After 5 min of incubation on ice,
release of nuclei was assessed by Trypan blue staining. Nuclei were
sedimented in a microcentrifuge for 10 s at 4uC and were then
resuspended in 2 pellet volumes of buffer C (20 mM HEPES, 25%
glycerol, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, with
inhibitor cocktail). The total volume of the nuclei was measured.
One volume of buffer C containing 840 mM NaCl was added, and
then nuclei were extracted for 20 min on ice, with occasional
mixing. After determination of protein concentrations of the
nuclear extracts by BCA assay (Bio-Rad: (Benicia-CA, USA)),
nuclear extract (10 ug) was added to binding buffer (10 mM Tris
pH 7.5, 0.5 mM MgCl2, 80 mM NaCl, 2.5 mM DTT, 4%
glycerol, 1 mM b-mercaptoethanol, 20 ml) in the presence or
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molar excess of the unlabeled probe was added and the samples
were preincubated for 20 min. After 1 h of incubation on ice, the
binding complexes were run in a 5% polyacrylamide gel in 0.25
TBE buffer (50 mM Tris, Boric acid, 1 mM EDTA pH 8, 4%
glycerol) at 30 mA for 3 h at 4uC following pre-running at the
same condition for 1 h.
Transient transfection assay and plasmids
IL-4 minimal promoter locus (2632,327) was amplified by
PCR and cloned into pGL4 basic vector. SATB1/JunB and
cofactors, p300 or/and PCAF expression plasmids were obtained
from Korean Unigene Information (KUGI, Daejeon, Korea), and
DNA sequences of each vector were confirmed by DNA
sequencing analysis (Solgent Co., Daejeon, Korea). HEK cells
were transfected by using Fugene 6 (Roche, Germany). An
amount of 0.3 mg of the promoter luciferase reporter vector and
0.1 mg of pRL-TK resuspended in 100 ml containing 0.6 ml
Fugene6 reagents was added to 2610
6 HEK-T cells. After a
16 h culture, rested cells were treated with 50 ng/ml PMA and
1 mM ionomycin for 6 h, and luciferase activity was measured by
the dual luciferase assay system (Promega: Madison, WI)
according to the manufacturer’s instructions. Data were normal-
ized by the activity of Renilla luciferase.
Micro-LC/LC-MS/MS Analysis
To ideintify and charactrize the transcription factors bound to
IL-4 promoter, micro-LC/LC-MS/MS analysis was performed
essentially as described [44] with minor modifications. The
nuclear extracts in Jurkat T cells or Th2 cells differentiated above
mentioned method were prepared. After running, polyacrylamide
gel were isolated corresponding to X-film band and then gel bands
showing differential mobility shift were cut and analyzed by micro-
LC/LC-MS/MS analysis. The identity of peptides were analyzed
by protein database search [45].
Statistical analysis
P values of ,0.05 obtained with a two-tailed Student t-test were
considered significant. Single asterisks (*) indicate p,0.05; double
asterisks (**) indicate p,0.005.
Supporting Information
Figure S1 Sustained IL-4 expression in NFAT1 deficient
Th2 cells. (A) Th2 cells differentiated from WT or NFAT1
deficient CD4
+T cells were left without stimulation or stimulated
with anti-CD3 (a-CD3) for indicated time periods. The relative
amount of nuclear NFAT1 protein levels was analyzed by Western
blot. The effect of cyclosporine A (CsA), a calcineurin inhibitor,
was also measured by adding CsA 30 min before stimulation.
Lamin B level was measured as an internal control for nuclear
protein extract. (B) The amount of IL-4 protein level from Th2
cells stimulated with a-CD3 for 36 h was measured by ELISA (B).
Data shown are the mean 6 SEM, from four separate experiments
and * P,0.05.
(TIF)
Figure S2 Increased DNA demethylation status at the
IL-4 promoter of NFAT1 deficient Th2 cells. Th2 cells from
WT or NFAT1 KO mice were stimulated with anti-CD3 for 6 h
or left without stimulation. DNA methylation state at the IL-4
promoter was analyzed by pyrosequencing. (A) The two targeted
cytosines are underlined in original and converted sequences. (B)
‘T’ peaks (arrowed) indicate methylated cytosine while ‘C’
indicates unmethylated cytosine. The positive control, non-CpG
cytosine residue showing complete conversion of cytosine to uracil
by bisulphite treatment (asterisk) and non reactive C residue in
yellow as negative control. First cytosine residue is unchanged in
WT and NFAT KO upon stimulation, while second cytosine
residue demonstrates a significant change in methylation. The
Methylation Index (MtI) percentage is calculated as the average
rate of G incorporation at each CpG. One representative of three
independent experiments is shown.
(TIF)
Figure S3 Constitutive expression of SATB1. Th2 cells
differentiated from WT or NFAT1 deficient CD4
+ T cells were left
without stimulation or stimulated with anti-CD3 for 6 h. The
relative level of nuclear SATB1 was analyzed by Western blot.
Tubulin and LaminB1 were used as controls.
(TIF)
Figure S4 Pivotal role of JUNB in IL-4 gene expression.
(A) Th2 cells from WT or NFAT1 deficient were left without
stimulation or stimulated for 6 h. The expression levels of JunB
and IL-4 were measured by agarose gel electophoresis. (B) Th2
cells from WT and NFAT1 deficient mice were transfected with
scrambled mock siRNA (Mock) or JunB specific siRNA (si-JunB)
and then specific knockdown efficiency of JunB and its effect on
IL-4 expression level was measured by agarose gel electrophoresis.
(TIF)
Figure S5 No significant increase of NFAT2, NFAT4,
JUNB and other transcription factor in NFAT1 deficient
Th2 cells. (A) Th2 cells from WT or NFAT1 deficient were left
without stimulation or stimulated for 6 h and then relative levels of
diverse transcription factors using nuclear extract were compared
by Western analysis. (B). Immunocytochemistry was performed to
compare the nuclear levels of JUNB between WT and NFAT1
deficient Th2 cells after stimulation with a-CD3 for 0 or 6 h.
FluoView microscope was used to analyze the stained cells; JUNB
(FITC, blue), 7-Aminoactinomycin D (7-AAD, nuclear, red),
merged (pink) and DIC (differential interference contrast).
(TIF)
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